Early low-dose rituximab for active thyroid eye disease: An effective and well-tolerated treatment

scientific article published on 11 April 2019

Early low-dose rituximab for active thyroid eye disease: An effective and well-tolerated treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEN.13970
P698PubMed publication ID30864162

P50authorZuzana SipkovaQ89403840
Elizabeth A InsullQ92319431
Helen E TurnerQ92319434
P2093author name stringJonathan H Norris
Joel David
P433issue1
P921main subjectrituximabQ412323
eye diseaseQ3041498
P304page(s)179-186
P577publication date2019-04-11
P1433published inClinical EndocrinologyQ15762781
P1476titleEarly low-dose rituximab for active thyroid eye disease: An effective and well-tolerated treatment
P478volume91

Search more.